Cited by 208Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

The neuropathology associated with repeat expansions in the C9ORF72 gene

Mackenzie, Ian R. A., Frick, Petra, Neumann, Manuela·2014·Acta Neuropathologica

DOI 10.1007/s00401-013-1232-4

Open this paper in CoChat — free account

Abstract

An abnormal expansion of a GGGGCC hexanucleotide repeat in a non-coding region of the chromosome 9 open reading frame 72 gene (C9ORF72) is the most common genetic abnormality in familial and sporadic FTLD and ALS and the cause in most families where both, FTLD and ALS, are inherited. Pathologically, C9ORF72 expansion cases show a combination of FTLD-TDP and classical ALS with abnormal accumulation of TDP-43 into neuronal and oligodendroglial inclusions consistently seen in the frontal and temporal cortex, hippocampus and pyramidal motor system. In addition, a highly specific feature in C9ORF72 expansion cases is the presence of ubiquitin and p62 positive, but TDP-43 negative neuronal cytoplasmic and intranuclear inclusions. These TDP-43 negative inclusions contain dipeptide-repeat (DPR) proteins generated by unconventional repeat-associated translation of C9ORF72 transcripts with the expanded repeats and are most abundant in the cerebellum, hippocampus and all neocortex regions. Another consistent pathological feature associated with the production of C9ORF72 transcripts with expanded repeats is the formation of nuclear RNA foci that are frequently observed in the frontal cortex, hippocampus and cerebellum. Here, we summarize the complexity and heterogeneity of the neuropathology associated with the C9ORF72 expansion. We discuss implications of the data to the current classification of FTLD and critically review current insights from clinico-pathological correlative studies regarding the fundamental questions as to what processes are required and sufficient to trigger neurodegeneration in C9ORF72 disease pathogenesis.

Integrity signals

Registry

Crossref · 10.1007/s00401-013-1232-4

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Self-citation
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
Self-citation
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Broeckhoven, C. V., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,248
Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,127
A harmonized classification system for FTLD-TDP pathology
Mackenzie, I. R., Neumann, M., Baborie, A., Sampathu, D. M., du Plessis, D., Jaros, E., Perry, R. H., Trojanowski, J. Q., Mann, D. M. A., & Lee, V. M. ‐. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0845-8 · Cited by 1,042
Self-citation
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
Mackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0612-2 · Cited by 1,012
Self-citation
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
Mackenzie, I. R., Rademakers, R., & Neumann, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70195-2 · Cited by 1,012
Self-citation
Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992
Self-citation
Non-ATG–initiated translation directed by microsatellite expansions
Zu, T., Gibbens, B. B., Doty, N. S., Gomes-Pereira, M., Huguet-Lachon, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 928

Show all 69 references

Sorted by citations

Items 101–200 of 208

RETRACTED ARTICLE: A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD
Hukema, R. K., Riemslagh, F. W., Melhem, S., van der Linde, H. C., Severijnen, L.-A. W. F. M., Edbauer, D., Maas, A., Charlet‐Berguerand, N., Willemsen, R., & Swieten, J. C. V. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0166-y · Cited by 27
Retracted
ANXA11 mutations are associated with amyotrophic lateral sclerosis–frontotemporal dementia
Wang, Y., Duan, X., Zhou, X., Wang, R., Zhang, X., Cao, Z., Wang, X., Zhou, Z., Sun, Y., & Peng, D. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.886887 · Cited by 27
A network of RNA and protein interactions in Fronto Temporal Dementia
Fontana, F., Siva, K., & Denti, M. A. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00009 · Cited by 30
Nuclear pore complex and nucleocytoplasmic transport disruption in neurodegeneration
Chandía-Cristi, A., Rapuri, S., & Coyne, A. N. (2023) · FEBS Letters · doi:10.1002/1873-3468.14729 · Cited by 29
Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids
van der Geest, A. T., Jakobs, C. E., Ljubikj, T., Huffels, C. F. M., Luna, M. C., de Sá, R. V., Adolfs, Y., de Wit, M., Rutten, D. H., Kaal, M., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01857-1 · Cited by 26
Blocking RAN translation without altering repeat RNAs rescues C9ORF72 -related ALS and FTD phenotypes
Jiang, X., Schaeffer, L., Patni, D., Russo, T., Lee, C.-Z., Aguilar, C., Marques, C., Jansen‐West, K. R., Hruška-Plocháň, M., Ray-Soni, A., et al. (2026) · Science · doi:10.1126/science.adv2600 · Cited by 22
Genetic forms of frontotemporal lobar degeneration: Current diagnostic approach and new directions in therapeutic strategies
Sellami, L., Saracino, D., & Ber, I. L. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.02.008 · Cited by 23
Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials
Querin, G., Biferi, M. G., & Pradat, P. (2021) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-210754 · Cited by 20
Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation
Castelnovo, V., Caminiti, S. P., Riva, N., Magnani, G., Silani, V., & Perani, D. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3685-7 · Cited by 20
Ultra-high field (7T) functional magnetic resonance imaging in amyotrophic lateral sclerosis: a pilot study
Barry, R. L., Babu, S., Anteraper, S. A., Triantafyllou, C., Keil, B. R., Rowe, O., Rangaprakash, D., Paganoni, S., Lawson, R. J., Dheel, C. M., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102648 · Cited by 20
Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models
Chen, L., Shao, Q., Zhang, W., Yang, M., Chang, Q., Chen, R., & Chen, J. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz230 · Cited by 20
Identification of a novel loss-of-function C9orf72 splice site mutation in a patient with amyotrophic lateral sclerosis
Liu, F., Liu, Q., Lu, C. X., Cui, B., Guo, X. N., Wang, R. R., Liu, M. S., Li, X. G., Cui, L., & Zhang, X. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.027 · Cited by 22
Motor and extra-motor gray matter integrity may underlie neurophysiologic parameters of motor function in amyotrophic lateral sclerosis: a combined voxel-based morphometry and transcranial stimulation study
Christidi, F., Karavasilis, E., Velonakis, G., Rentzos, M., Zambelis, T., Zouvelou, V., Xirou, S., Ferentinos, P. P., EFSTATHOPOULOS, E. P., Kelekis, N., et al. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9841-0 · Cited by 19
Prevalence of C9ORF72 Expansion in a Large Series of Patients with Idiopathic Normal-Pressure Hydrocephalus
Korhonen, V. E., Remes, A. M., Helisalmi, S., Rauramaa, T. H., Sutela, A., Vanninen, R. L., Suhonen, N., Haapasalo, A., Hiltunen, M., Jääskeläinen, J. E., et al. (2019) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000497306 · Cited by 18
Modeling Als Using Ipscs: is It Possible to Reproduce the Phenotypic Variations Observed in Patients in vitro ?
Vasques, J. F., Méndez‐Otero, R., & Gubert, F. (2020) · Regenerative Medicine · doi:10.2217/rme-2020-0067 · Cited by 18
C9orf72; abnormal RNA expression is the key
Heutink, P., Jansen, I. E., & Lynes, E. M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.020 · Cited by 17
Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M)
Domoto‐Reilly, K., Davis, M. Y., Keene, C. D., & Bird, T. D. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32443 · Cited by 17
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies
Reyes‐Leiva, D., Dols‐Icardo, O., Sirisi, S., Cortés‐Vicente, E., Turón‐Sans, J., de Luna, N., Blesa, R., Belbin, O., Montal, V., Alcolea, D. A., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.750543 · Cited by 18
Glycine-Alanine Dipeptide Repeat Protein from C9-ALS Interacts with Sulfide Quinone Oxidoreductase (SQOR) to Induce the Activity of the NLRP3 Inflammasome in HMC3 Microglia: Irisflorentin Reverses This Interaction
Fu, R., Chen, H., & Hong, S. (2023) · Antioxidants · doi:10.3390/antiox12101896 · Cited by 15
Axonopathy Underlying Amyotrophic Lateral Sclerosis: Unraveling Complex Pathways and Therapeutic Insights
Luan, T., Li, Q., Huang, Z., Feng, Y., Xu, D., Zhou, Y., Hu, Y., & Wang, T. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01267-2 · Cited by 15
Clinicopathological correlates in the frontotemporal lobar degeneration–motor neuron disease spectrum
Carbayo, Á., Borrego‐Écija, S., Turón‐Sans, J., Cortés‐Vicente, E., Molina‐Porcel, L., Gascón‐Bayarri, J., Rubio, M. Á., Povedano, M., Gámez, J., Sotoca, J., et al. (2024) · Brain · doi:10.1093/brain/awae011 · Cited by 15
Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models
Chen, L., Shao, Q., Zhang, W., Yang, M., Chang, Q., Chen, R., & Chen, J. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa012 · Cited by 14
Intermediate length C9orf72 expansion in an ALS patient without classical C9orf72 neuropathology
Beer, A. M., Cooper‐Knock, J., Higginbottom, A., Highley, J. R., Wharton, S. B., Ince, P. G., Milano, A., Jones, A., Al‐Chalabi, A., Kirby, J., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.977296 · Cited by 12
C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice
Lopez-Herdoiza, M.-B., Bauché, S., Wilmet, B., Duigou, C. L., Roussel, D., Frah, M., Béal, J., Devely, G., Boluda, S., Frick, P., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1155929 · Cited by 13
Self-citation
Stress-induced acidification may contribute to formation of unusual structures in C9orf72-repeats
Zamiri, B., Mirceta, M., Abu‐Ghazalah, R. M., Wold, M. S., Pearson, C. E., & Macgregor, R. B. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.03.001 · Cited by 12
Thermoregulation in amyotrophic lateral sclerosis
Dupuis, L., Petersén, Å., & Weydt, P. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64074-1.00046-x · Cited by 13
Pure argyrophilic grain disease revisited: independent effects on limbic, neocortical, and striato-pallido-nigral degeneration and the development of dementia in a series with a low to moderate Braak stage
Yokota, O., Miki, T., Nakashima‐Yasuda, H., Ishizu, H., Haraguchi, T., Ikeda, C., Hasegawa, M., Miyashita, A., Ikeuchi, T., Nishikawa, N., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01828-6 · Cited by 11
Development of neurodegeneration in amyotrophic lateral sclerosis: from up or down?
Geser, F., Fellner, L., Haybaeck, J., & Wenning, G. K. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02213-y · Cited by 13
Generation and Characterization of Novel Monoclonal Antibodies Targeting p62/sequestosome-1 Across Human Neurodegenerative Diseases
Trejo‐Lopez, J. A., Sorrentino, Z. A., Riffe, C. J., Prokop, S., Dickson, D. W., Yachnis, A. T., & Giasson, B. I. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa007 · Cited by 12
Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia
Gagliardi, D., Costamagna, G., Taiana, M. M., Andreoli, L., Biella, F., Bersani, M., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101172 · Cited by 11
Amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Hortobágyi, T., & Cairns, N. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.012 · Cited by 10
Limbic Network and Papez Circuit Involvement in ALS: Imaging and Clinical Profiles in GGGGCC Hexanucleotide Carriers in C9orf72 and C9orf72-Negative Patients
Christidi, F., Kleinerová, J., Tan, E. L., Delaney, S., Tacheva, A., Hengeveld, J. C., Doherty, M. A., McLaughlin, R. L., Hardiman, O. M., Siah, W. F., et al. (2024) · Biology · doi:10.3390/biology13070504 · Cited by 10
Frontotemporal lobar dementia and amyotrophic lateral sclerosis associated with c9orf72 expansion
Ber, I. L. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.04.004 · Cited by 8
Analysis of Heritability Across the Clinical Phenotypes of Frontotemporal Dementia and the Frequency of the C9ORF72 in a Colombian Population
López, A., Velasco-Rueda, M., Garcia-Cifuentes, E. R., Zarante, I., & Matallana, D. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.681595 · Cited by 8
Reduced mtDNA Copy Number in the Prefrontal Cortex of C9ORF72 Patients
Álvarez‐Mora, M. I., Podlesniy, P., Riazuelo, T., Molina‐Porcel, L., Gelpí, E., & Rodríguez‐Revenga, L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02673-7 · Cited by 8
Bioenergetic and Autophagic Characterization of Skin Fibroblasts from C9orf72 Patients
Álvarez‐Mora, M. I., Garrabou, G., Barcos, T., Garcia‐García, F., Grillo-Risco, R., Peruga, E., Gort, L., Borrego‐Écija, S., Sánchez‐Valle, R., Cantó, J., et al. (2022) · Antioxidants · doi:10.3390/antiox11061129 · Cited by 8
A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations
Coppola, C., Saracino, D., Puoti, G., Lus, G., Dato, C., Ber, I. L., Pariente, J., Caroppo, P., Piccoli, E., Tagliavini, F., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.008 · Cited by 10
Extracellular vesicles in neurodegenerative disorders
Mäger, I., Willms, E., Bonner, S. E., Hill, A. F., & Wood, M. J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816053-4.00012-2 · Cited by 8
Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond
Saracino, D., & Ber, I. L. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_5 · Cited by 7
C9ORF72 Intermediate Repeat Expansion in a Patient With Psychiatric Disorders and Progressive Cerebellar Ataxia
Meloni, M., Farris, R., Solla, P., Mascia, M. M., Marrosu, F., & Cannas, A. (2017) · The Neurologist · doi:10.1097/nrl.0000000000000147 · Cited by 7
TDP-43 Proteinopathies in ALS and FTLD: Mechanistic Insights and Therapeutic Approaches
Chauhan, S., Maan, P., & Panghal, A. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273374466250617085832 · Cited by 6
How can we define the presymptomatic C9orf72 disease in 2022? An overview on the current definitions of preclinical and prodromal phases
Saracino, D., & Ber, I. L. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.007 · Cited by 7
C9ORF72 Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia
Zubizarreta, I. K., Manero-Azua, Á., Afonso-Agüera, J., & de Nanclares, G. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091396 · Cited by 8
Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic
Tang, S.-S., Li, J., Tan, L., & Yu, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160236 · Cited by 5
HDAC6 Interacts With Poly (GA) and Modulates its Accumulation in c9FTD/ALS
del Rosso, G., Carlomagno, Y., Todd, T. W., Jones, C. Y., Prudencio, M., Daughrity, L. M., Yue, M., Jansen‐West, K. R., Tong, J., Shao, W., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809942 · Cited by 5
Amyotrophic Lateral Sclerosis 1 and Many Diseases
Ratti, E., & Berry, J. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00042-1 · Cited by 5
Loss of nucleoporin Nup50 is a risk factor for amyotrophic lateral sclerosisPreprint
Megat, S., Mora, N., Sanogo, J., Catanese, A., Alami, N. O., Freischmidt, A., Mingaj, X., de Calbiac, H., Muratet, F., Dirrig‐Grosch, S., et al. (2021) · medRxiv · doi:10.1101/2021.08.23.21262299 · Cited by 6
The potential of TDP-43 PET ligands for a biological diagnosis of TDP-43 proteinopathies
Irwin, D. J. (2025) · Nature Communications · doi:10.1038/s41467-025-64541-5 · Cited by 7
C9orf72 Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice
Hatanaka, Y., Umeda, T., Shigemori, K., Takeuchi, T., Nagai, Y., & Tomiyama, T. (2022) · Biomedicines · doi:10.3390/biomedicines10051080 · Cited by 5
The Lysosome in Aging‐Related Neurodegenerative Diseases
Nixon, R. A. (2016) · Wiley eBooks · doi:10.1002/9781118978320.ch9 · Cited by 5
Reversing lysosome-ribosome circuit dysregulation mitigates C9FTD/ALS neurodegeneration and behaviors
Ma, L., Chen, L., Wang, J., Chang, Q., Wang, Y., Zhang, W., Du, Y., Sadan, J., & Chen, J. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac271 · Cited by 4
Pathology and pathophysiology
Dickerson, B. C. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781316091586.016 · Cited by 4
New insights in the diagnosis and treatment of amyotrophic lateral sclerosis
Štětkářová, I., Matěj, R., & Ehler, E. (2018) · Česká a slovenská neurologie a neurochirurgie · doi:10.14735/amcsnn2018546 · Cited by 4
Resting-state functional MRI in behavioral variant of frontotemporal dementia
Rytty, R. (2016) · Cited by 3
Sessions 1 - 11
(2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1089039 · Cited by 4
La sclérose latérale amyotrophique : une maladie neurodégénérative emblématique
Viader, F. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2023.01.002 · Cited by 3
Co‐incidental C9orf72 expansion mutation‐related frontotemporal lobar degeneration pathology and sporadic Creutzfeldt−Jakob disease
Klotz, S., König, T., Erdler, M., Ulram, A., Nguyen, A., Ströbel, T., Zimprich, A. A., Stögmann, E., Regelsberger, G., Höftberger, R., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14621 · Cited by 3
Introduction
Bendotti, C., Bonetto, V., & Migheli, A. (2016) · Brain Pathology · doi:10.1111/bpa.12349 · Cited by 3
RuvBL1/2 reduce toxic dipeptide repeat protein burden in multiple models of C9orf72-ALS/FTD
Webster, C. P., Hall, B., Crossley, O. M., Dauletalina, D., King, M., Lin, Y.-H., Castelli, L. M., Yang, Z.-L., Coldicott, I., Kyrgiou-Balli, E., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402757 · Cited by 2
Alzheimer's Disease Co‐Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis
Kasper, E., Lehto, A., Jürs, A. V., Nordmann, N., Peters, O., Hellmann, J., Priller, J., Spruth, E. J., Petzold, G. C., Voigt, I., et al. (2026) · Annals of Neurology · doi:10.1002/ana.78227 · Cited by 2
Self-citation
Zebrafish C9orf72 loss-of-function models of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Rounding, N. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 2
Two Sides of the Same Coin: Genes Involved in Neurodegeneration and Cancer
Montanari, M., Meringolo, M., Atiallah, I. E., Renna, A., & Martella, G. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_216 · Cited by 1
C9ORF72 repeat expansion: a genetic mutation associated with Amyotrophic Lateral Sclerosis
Vats, K., Verma, M., Gourie‐Devi, M., & Taneja, V. (2014) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2014.07.002 · Cited by 2
Geneticsof frontotemporal dementia and related disorders
Cruts, M., & Broeckhoven, C. V. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781316091586.017 · Cited by 1
Mechanisms of Dendrite Degeneration in Amyotrophic Lateral Sclerosis
Lee, S., Shang, Y., & Huang, E. J. (2016) · Springer eBooks · doi:10.1007/978-4-431-56050-0_21 · Cited by 1
Formes génétiques des dégénérescences lobaires frontotemporales : où en sommes-nous et où allons-nous ?
Ber, I. L. (2017) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2017.01.024 · Cited by 1
Investigation of cerebellar damage in adult amyotrophic lateral sclerosis patients using magnetic resonance imaging and diffusion tensor imaging
Nowakowska-Kotas, M. M., Korbecki, A., Budrewicz, S. P., & Bladowska, J. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/172698 · Cited by 1
Neuropsychiatric Manifestations of Amyotrophic Lateral Sclerosis
Kim, H. (2024) · Springer eBooks · doi:10.1007/978-981-97-1821-4_17 · Cited by 1
Fluid and Imaging Markers of Frontotemporal Lobar Degeneration
Prinse, F., Houwer, J. F. H. D., Dopper, E. G. P., & Seelaar, H. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_9 · Cited by 1
Two Families with SOD1 (L144F) and C9orf72 Gene Mutations and an Overview of Amyotrophic Lateral Sclerosis
Bülbül, N. G., Seçıl, Y., Basak, N. A., Beckmann, Y. Y., Türe, H. S., Tunca, C., & Özoğuz, A. (2018) · Turkish Journal Of Neurology · doi:10.4274/tnd.26214 · Cited by 1
Late-onset spinal motor neuronopathy- a new neuromuscular disease
Jokela, M. E. (2015) · UTUPub (University of Turku) · Cited by 1
neuroprotective and neuropathologic evidence
McMillan, C. T., Russ, J., Wood, E. M., Irwin, D. J., Grossman, M., McCluskey, L. F., Elman, L. B., Deerlin, V. M. V., & Lee, E. B. (2015)
Retraction Note to: A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD
Hukema, R. K., Riemslagh, F. W., Melhem, S., van der Linde, H. C., Severijnen, L.-A. W. F. M., Edbauer, D., Maas, A., Charlet‐Berguerand, N., Willemsen, R., & Swieten, J. C. V. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0401-9
Retracted
Clinical and laboratory features of ALS
Xu, Z. (2018) · The University of Queensland · doi:10.14264/uql.2018.143
A 59-Year-Old Man with Weakness and Personality Changes
Choudhury, P., Jewett, G., Numerow, L., Korngut, L. W., & Pfeffer, G. (2021) · Cambridge University Press eBooks · doi:10.1017/9781316941294.010
Characterizing Cerebral Degeneration in Amyotrophic Lateral Sclerosis with Texture Analysis
Ishaque, A. H. (2020) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-65xc-5r84
Motoneuronerkrankungen
Prudlo, J., & Hermann, A. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-21882-8.00007-4
The Motor Neuron Diseases and Amyotrophic Lateral Sclerosis
Lewis, P. A., & Spillane, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811069-0.00005-7 · Cited by 1
Review: Applications of Artificial Intelligence in Dementia Research — R0/PR3
(2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2022.10.pr3
Decision: Applications of Artificial Intelligence in Dementia Research — R1/PR8
(2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2022.10.pr8
Review: Applications of Artificial Intelligence in Dementia Research — R0/PR2
(2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2022.10.pr2
Decision: Applications of Artificial Intelligence in Dementia Research — R0/PR5
(2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2022.10.pr5
Recommendation: Applications of Artificial Intelligence in Dementia Research — R1/PR7
(2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2022.10.pr7
Author comment: Applications of Artificial Intelligence in Dementia Research — R1/PR6
Tsoi, K. K. F. (2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2022.10.pr6
Recommendation: Applications of Artificial Intelligence in Dementia Research — R0/PR4
(2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2022.10.pr4
Author comment: Applications of Artificial Intelligence in Dementia Research — R0/PR1
Tsoi, K. K. F. (2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2022.10.pr1
G 2 C 4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in C9orf72 ALS/FTD human neuronsPreprint
Rothstein, J. D., Baskerville, V., Rapuri, S., Mehlhop, E., Jafar‐Nejad, P., Rigo, F., Bennett, F., Mizielinska, S., Isaacs, A. M., & Coyne, A. N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.26.546581
Additional file 3 of A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons
Beckers, J., Tharkeshwar, A. K., Fumagalli, L., Contardo, M., Schoor, E. V., Fazal, R., Thal, D. R., Chandran, S., Mancuso, R., Bosch, L. V. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24159426
Additional file 2 of A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons
Beckers, J., Tharkeshwar, A. K., Fumagalli, L., Contardo, M., Schoor, E. V., Fazal, R., Thal, D. R., Chandran, S., Mancuso, R., Bosch, L. V. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24159423
Degenerazioni lobari frontotemporali: neuropatologia, genetica e classificazione
Saracino, D., Ber, I. L., & Deramecourt, V. (2024) · EMC - Neurologia · doi:10.1016/s1634-7072(24)49339-2
Extracellular vesicles as biomarker and therapeutic targets for neurological disorders
Razi, U., Ahmad, F., Karan, A., Sundar, V., & DeCoster, M. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23891-8.00007-x
Literaturverzeichnis
(2022) · Elsevier eBooks · doi:10.1016/b978-3-437-21884-2.00033-7
Glial cell-intrinsic and non-cell autonomous toxicity in a Drosophila C9orf72 neurodegeneration modelPreprint
Hubbard, I., & Dubnau, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.07.680869
Brain metabolic connectivity in ALS due to C9ORF72 hexanucleotide expansion: a [18F]FDG-PET study
Canosa, A., Callegaro, S., Manera, U., Vasta, R., Cabras, S., Pede, F. D., Mattei, F. D., Palumbo, F., Iazzolino, B., Giudici, A. D., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07705-1
Additional file 3 of Pure argyrophilic grain disease revisited: independent effects on limbic, neocortical, and striato-pallido-nigral degeneration and the development of dementia in a series with a low to moderate Braak stage
Yokota, O., Miki, T., Nakashima‐Yasuda, H., Ishizu, H., Haraguchi, T., Ikeda, C., Hasegawa, M., Miyashita, A., Ikeuchi, T., Nishikawa, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26756329
Additional file 1 of A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons
Beckers, J., Tharkeshwar, A. K., Fumagalli, L., Contardo, M., Schoor, E. V., Fazal, R., Thal, D. R., Chandran, S., Mancuso, R., Bosch, L. V. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24159420
Additional file 4 of Pure argyrophilic grain disease revisited: independent effects on limbic, neocortical, and striato-pallido-nigral degeneration and the development of dementia in a series with a low to moderate Braak stage
Yokota, O., Miki, T., Nakashima‐Yasuda, H., Ishizu, H., Haraguchi, T., Ikeda, C., Hasegawa, M., Miyashita, A., Ikeuchi, T., Nishikawa, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26756332
Additional file 2 of Pure argyrophilic grain disease revisited: independent effects on limbic, neocortical, and striato-pallido-nigral degeneration and the development of dementia in a series with a low to moderate Braak stage
Yokota, O., Miki, T., Nakashima‐Yasuda, H., Ishizu, H., Haraguchi, T., Ikeda, C., Hasegawa, M., Miyashita, A., Ikeuchi, T., Nishikawa, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26756326
Additional file 5 of Pure argyrophilic grain disease revisited: independent effects on limbic, neocortical, and striato-pallido-nigral degeneration and the development of dementia in a series with a low to moderate Braak stage
Yokota, O., Miki, T., Nakashima‐Yasuda, H., Ishizu, H., Haraguchi, T., Ikeda, C., Hasegawa, M., Miyashita, A., Ikeuchi, T., Nishikawa, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26756335
Additional file 1 of Pure argyrophilic grain disease revisited: independent effects on limbic, neocortical, and striato-pallido-nigral degeneration and the development of dementia in a series with a low to moderate Braak stage
Yokota, O., Miki, T., Nakashima‐Yasuda, H., Ishizu, H., Haraguchi, T., Ikeda, C., Hasegawa, M., Miyashita, A., Ikeuchi, T., Nishikawa, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26756323

Authors: Mackenzie, I. R. A., Frick, P., & Neumann, M.
Affiliations: University of British Columbia (CA)
German Center for Neurodegenerative Diseases (DE)
Corresponding author: Neumann, Manuela
ORCID: Mackenzie, Ian R. A.
Neumann, Manuela
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2013-12-20
Volume: 127
Issue: 3
Pages: 347-357
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-013-1232-4
OpenAlex: W2121553631
Cited by: 206
References: 69
Citations by year: 2026: 4 · 2025: 6 · 2024: 17 · 2023: 13 · 2022: 20 · 2021: 14 · 2020: 17 · 2019: 17 · 2018: 20 · 2017: 16 · 2016: 23 · 2015: 28 · 2014: 11
FWCI: 2.71
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
DZNE Pub (submittedVersion)
Funders: Canadian Institutes of Health Research (74580)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: C9orf72, GGGGCC repeat expansion, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, TDP-43, dipeptide repeat proteins, repeat-associated non-AUG translation, ubiquitin-positive inclusions, p62, neurodegeneration, neuropathology, FTLD-TDP
MeSH terms: C9orf72 Protein, Brain, DNA-Binding Proteins, Humans, Phenotype, Proteins, Neurodegenerative Diseases, DNA Repeat Expansion, Frontotemporal Lobar Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The neuropathology associated with repeat expansions in the C9ORF72 gene

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks